Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
SI-BONE
SIBN
SI-BONE
Rising US Reimbursement Risk Will Curb Opportunities Yet Allow Recovery
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
08 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$20.00
18.0% undervalued
intrinsic discount
16 Aug
US$16.39
Loading
1Y
-3.6%
7D
5.5%
Author's Valuation
US$20.0
18.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$20.0
18.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-66m
278m
2014
2017
2020
2023
2025
2026
2028
Revenue US$278.2m
Earnings US$34.6m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
14.19%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.59%
Calculation
US$34.56m
Earnings '28
x
33.88x
PE Ratio '28
=
US$1.17b
Market Cap '28
US$1.17b
Market Cap '28
/
47.79m
No. shares '28
=
US$24.50
Share Price '28
US$24.50
Share Price '28
Discounted to 2025 @ 7.60% p.a.
=
US$19.67
Fair Value '25
